GLYCATION INHIBITORS AND PROBIOTICS CAN AMELIORATE THE CHANGES CAUSED BY HIGH FRUCTOSE FEED
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2018, Vol 10, Issue 7
Abstract
Objective: To evaluate the use of protein glycation inhibitors and probiotics to ameliorate secondary complications in diabetes and to improve gut microbiota respectively in high fructose fed Wistar rat.Methods: The study was conducted on male Wistar rats for 7 d. Blood glucose levels in oral glucose tolerance test (OGTT) were measured using glucometer, serum parameters were analyzed using commercial kits, antioxidant status was evaluated by measuring superoxide dismutase (SOD) and catalase (CAT) levels, total reactive oxygen species were estimated using a fluorescent 2’, 7’-dichlorofluorescin diacetate (DCF-DA) dye, and tissue fluorescence of liver, kidney and intestine were measured using a spectrofluorimeter.Results: OGTT pattern shows significant increase in blood glucose of fructose fed rats i.e. 154 mg/dl while, in aminoguanidine (AMG) treated and gut microbiota modulated animals it is 137 and 119 mg/dl resp. after 30 min on glucose administration. Marked reduction was found in SOD 6.37 and 11.25 U/mg of protein and catalase 186 and 65.5 U/mg of protein in liver and kidney of fructose fed animals when compared to fructose+AMG and fructose+EUGI. There is 5-6 fold significant increase in general and specific tissue fluorescence of liver and kidney, and 2.2 fold increase in liver reactive oxygen species was observed in fructose fed group as compare to control animals. Significantly higher glycation was found in intestine of fructose fed animals (general fluorescence 2.1 and specific fluorescence 3.1 AU/mg), more than that of diabetic control rats (general fluorescence 0.9 and specific fluorescence 1.6 AU/mg), represented an evidence for adverse impact of excess fructose on healthy gut.Conclusion: The use of protein glycation inhibitor and use of pre and probiotics significantly improved the serum parameters and would prevent progression to secondary complications.
Authors and Affiliations
Rahul S. Patil, Ashwini D. Jagdale, Megha L. Nalawade, Laxman N. Bavkar, Akalpita U. Arvindekar
Keywords
Related Articles
- EP ID EP566213
- DOI 10.22159/ijpps.2018v10i7.26870
- Views 42
- Downloads 0
CONDUCTOMETRIC DETERMINATION OF THE ANTIHISTAMINIC DIPHENHYDRAMINE HYDROCHLORIDE USING SILVER NITRATE AS A TITRANT
Objectives: The present study developed and validated a conductometric method for determination of Diphenhydramine HCl (DPH) in its pure form and in a syrup formulation using silver nitrate (AgNO3 ).Methods: Conductometr...
A STUDY ON SYMPTOMS, RISK FACTORS AND PRESCRIBING PATTERN OF DRUGS USED IN STROKE PATIENTS
Objective: This hospital based case study was undertaken with aim to identify the symptoms, risk factors and prescribing trends of medication employed in stroke. The objective of this study was to work out the prevalence...
BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF HCG (HUMAN CHORIONIC GONADOTROPIN)
Objective: To develop and validate simple, rapid, specific, accurate and precise bioanalytical method for determination of the HCG (Human Chorionic Gonadotropin) by RP-HPLC method by using human urine.Methods: The chroma...
ASSESSMENT OF KNOWLEDGE OF ZIKA VIRUS INFECTION AMONG HEALTH CARE PROFESSIONALS IN A SOUTHEASTERN STATE OF NIGERIA
Objective: Zika virus infection is fast becoming a major public health concern in both developed and developing countries of the world because of its association with microcephaly and Guillain Barre Syndrome. Assessment...
A MUCOADHESIVE GASTRORETENTIVE DOSAGE FORM FOR VALACYCLOVIR
Objective: The objective of the present work was to formulate a gastroretentive dosage form of Valacyclovir, an anti viral drug.Methods: Valacyclovir gastroretentive mucoadhesive tablets were prepared using polymers such...